News

Ten years after heading to Cannes with Alexander Payne's ‘Nebraska,' Squibb is back with ‘Eleanor the Great’ from director ...
Eleven-year follow-up data continue to show the invasive disease-free survival benefit for node-positive patients seen in previous analyses.
Pfizer-backed CellCentric has secured $120 million in series C funds as the British biotech prepares to take its multiple ...
Shares of Prime Medicine, Inc. (NASDAQ:PRME) fell 19.2% following the company’s announcement of a strategic restructuring ...
The revitalisation of GSK's blood cancer therapy Blenrep has continued with a second regulatory approval, in Japan, as a ...
A federal district court ruled in favor of the Health Resources and Services Administration, but raised questions about ...
Century Therapeutics, Inc. (NASDAQ: IPSC) reported notable progress in Q1 2025, emphasizing advancements in its clinical and preclinical iPSC-derived cell therapy programs. Highlights include updates ...